Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-31
2009-11-24
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S484000
Reexamination Certificate
active
07622462
ABSTRACT:
Compounds of the formula:or pharmaceutically acceptable salts, solvates or prodrugs thereof,wherein Ar, R1and R2are defined herein. Also provided are pharmaceutical compositions, methods of preparing the compounds, and method of using the compounds for treatment of monoamine reuptake inhibitor-mediated diseases.
REFERENCES:
patent: 5440033 (1995-08-01), Berger et al.
patent: 2006/0052378 (2006-03-01), Molino et al.
patent: WO 01/32624 (2001-05-01), None
patent: WO 2007/011820 (2007-01-01), None
Huang et al. Expert Opinion in Therapeutic Patents, 2007, 17)8), 889-907.
Krull et al. Bioorganic and Medicinal Chemistry, 2004, 12, 1439-51.
Schoenfeld Ryan Craig
Weikert Robert James
Hall Robert C.
Jarrell Noble
Roche Palo Alto LLC
Wilson James O
LandOfFree
Benzazepine derivatives and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzazepine derivatives and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzazepine derivatives and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4069843